| |
|
 |
|
| |
| |
AIMS AND OBJECTIVES
(A) To represent Pharmaceutical Physicians working in Australia.
The term pharmaceutical physician refers to a registered medical practitioner whose principal work is in the area of pharmaceutical medicine, a medical specialty concerned with the discovery, development, evaluation, licensing and monitoring of medicines, and the medical aspects of their marketing
(B) To facilitate the sharing of technical expertise and thereby foster the further education of pharmaceutical physicians within Australia; and
(C) To provide fellowship and dialogue between physicians working in pharmaceutical medicine in Australia.
We meet 3 or 4 times a year, usually in Sydney as the majority of our members are based there, although in April 2005 we held a meeting in Canberra. Topics are chosen to help give background knowledge from the relevant experiences of colleagues that may help manage issues that we could be faced with. Recent meeting topics have included a “meet the journalists” forum, a presentation on crisis management issues on the withdrawal of a major drug, and implications for drug regulation of recent critical issues. We will support the Association of Regulatory and Clinical Scientists (ARCS) Annual Scientific Meeting in 2005 with a workshop on issues relevant to the development of the next revision of the Code of Conduct for Medicines Australia.
Our annual general meeting is held in September or October of each year at which an Executive Committee is elected to administer the affairs of the Association.
APPA is developing important links with ARCS and the Drug Information Association (DIA) to facilitate tailoring and provision of services to our members, many of whom we share.
APPA is a member association of the International Federation of Associations of Pharmaceutical Physicians (IFAPP). A member of the APPA’s Executive Committee represents the Association on IFAPP’s Council for the Education in Pharmaceutical Medicine which has a syllabus against which various diploma level courses around the world are being accredited. In Australia APPA is working with the Faculty of the University of New South Wales courses on drug development to adapt and where necessary create the modules in to a full diploma course for which accreditation is planned in 2006. This is on track to be up and running for the start of the academic year in 2006.
|
|
|
|
|
 |
| |
|
